Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 811

1.

Esophageal cancer associated with a sarcoid-like reaction and systemic sarcoidosis in lymph nodes: supportive findings of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography during neoadjuvant therapy.

Kishino T, Okano K, Ando Y, Suto H, Asano E, Oshima M, Fujiwara M, Usuki H, Kobara H, Masaki T, Ibuki E, Kushida Y, Haba R, Suzuki Y.

Surg Case Rep. 2018 Jun 25;4(1):62. doi: 10.1186/s40792-018-0473-9.

2.

Author Correction: Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes.

Rouxel O, DaSilva J, Beaudoin L, Nel I, Tard C, Cagninacci L, Kiaf B, Oshima M, Diedisheim M, Salou M, Corbett A, Rossjohn J, McCluskey J, Scharfmann R, Battaglia M, Polak M, Lantz O, Beltrand J, Lehuen A.

Nat Immunol. 2018 Jun 7. doi: 10.1038/s41590-017-0023-9. [Epub ahead of print]

PMID:
29880894
3.

Development and characterization of transgenic dominant male sterile rice toward an outcross-based breeding system.

Abe K, Oshima M, Akasaka M, Konagaya KI, Nanasato Y, Okuzaki A, Taniguchi Y, Tanaka J, Tabei Y.

Breed Sci. 2018 Mar;68(2):248-257. doi: 10.1270/jsbbs.17090. Epub 2018 Mar 24.

4.

Pure laparoscopic pancreas parenchymal dissection using CUSA for distal pancreatectomy.

Okano K, Suto H, Oshima M, Ando Y, Asano E, Kishino T, Fujiwara M, Kobara H, Mori H, Masaki T, Suzuki Y.

Minim Invasive Ther Allied Technol. 2018 Jun 5:1-4. doi: 10.1080/13645706.2018.1479272. [Epub ahead of print]

PMID:
29869577
5.

Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer.

Kang MH, Choi H, Oshima M, Cheong JH, Kim S, Lee JH, Park YS, Choi HS, Kweon MN, Pack CG, Lee JS, Mills GB, Myung SJ, Park YY.

Nat Commun. 2018 May 15;9(1):1920. doi: 10.1038/s41467-018-04244-2.

6.

Efficacy of posterior decompression and fixation based on ossification-kyphosis angle criteria for multilevel ossification of the posterior longitudinal ligament in the thoracic spine.

Uei H, Tokuhashi Y, Oshima M, Maseda M, Nakahashi M, Nakayama E.

J Neurosurg Spine. 2018 May 4:1-7. doi: 10.3171/2017.12.SPINE17549. [Epub ahead of print]

PMID:
29726802
7.

Hematopoietic insults damage bone marrow niche by activating p53 in vascular endothelial cells.

Si S, Nakajima-Takagi Y, Iga T, Tsuji M, Hou L, Oshima M, Koide S, Saraya A, Yamazaki S, Takubo K, Kubota Y, Minamino T, Iwama A.

Exp Hematol. 2018 Jul;63:41-51.e1. doi: 10.1016/j.exphem.2018.04.006. Epub 2018 Apr 27.

PMID:
29709619
8.

Spred1 Safeguards Hematopoietic Homeostasis against Diet-Induced Systemic Stress.

Tadokoro Y, Hoshii T, Yamazaki S, Eto K, Ema H, Kobayashi M, Ueno M, Ohta K, Arai Y, Hara E, Harada K, Oshima M, Oshima H, Arai F, Yoshimura A, Nakauchi H, Hirao A.

Cell Stem Cell. 2018 May 3;22(5):713-725.e8. doi: 10.1016/j.stem.2018.04.002. Epub 2018 Apr 26.

PMID:
29706577
9.

Synaptic transmission from subplate neurons controls radial migration of neocortical neurons.

Ohtaka-Maruyama C, Okamoto M, Endo K, Oshima M, Kaneko N, Yura K, Okado H, Miyata T, Maeda N.

Science. 2018 Apr 20;360(6386):313-317. doi: 10.1126/science.aar2866.

PMID:
29674592
10.

18F-fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancer.

Okano K, Suto H, Oshima M, Ando Y, Nagao M, Kamada H, Kobara H, Masaki T, Okuyama H, Okita Y, Tsuji A, Suzuki Y.

Jpn J Clin Oncol. 2018 May 1;48(5):434-441. doi: 10.1093/jjco/hyy033.

PMID:
29590448
11.

Application of chromosomal gene insertion into Escherichia coli for expression of recombinant proteins.

Nakamura T, Koma D, Oshima M, Hoshino H, Ohmoto T, Uegaki K.

J Biosci Bioeng. 2018 Aug;126(2):266-272. doi: 10.1016/j.jbiosc.2018.02.016. Epub 2018 Mar 15.

PMID:
29551467
12.

Design and experimental force analysis of a novel elliptical vibration assisted orthopedic oscillating saw.

Shu L, Sugita N, Oshima M, Mitsuishi M.

Med Eng Phys. 2018 Apr;54:22-31. doi: 10.1016/j.medengphy.2018.02.005. Epub 2018 Feb 20.

PMID:
29475589
13.

Modeling human pancreatic beta cell dedifferentiation.

Diedisheim M, Oshima M, Albagli O, Huldt CW, Ahlstedt I, Clausen M, Menon S, Aivazidis A, Andreasson AC, Haynes WG, Marchetti P, Marselli L, Armanet M, Chimienti F, Scharfmann R.

Mol Metab. 2018 Apr;10:74-86. doi: 10.1016/j.molmet.2018.02.002. Epub 2018 Feb 8.

14.

The inflammatory microenvironment that promotes gastrointestinal cancer development and invasion.

Echizen K, Oshima H, Nakayama M, Oshima M.

Adv Biol Regul. 2018 May;68:39-45. doi: 10.1016/j.jbior.2018.02.001. Epub 2018 Feb 5. Review.

PMID:
29428221
15.

Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development.

Hill DG, Yu L, Gao H, Balic JJ, West A, Oshima H, McLeod L, Oshima M, Gallimore A, D'Costa K, Bhathal PS, Sievert W, Ferrero RL, Jenkins BJ, Jones GW.

Int J Cancer. 2018 Jul 1;143(1):167-178. doi: 10.1002/ijc.31298. Epub 2018 Feb 19.

16.

Virus-like infection induces human β cell dedifferentiation.

Oshima M, Knoch KP, Diedisheim M, Petzold A, Cattan P, Bugliani M, Marchetti P, Choudhary P, Huang GC, Bornstein SR, Solimena M, Albagli-Curiel O, Scharfmann R.

JCI Insight. 2018 Feb 8;3(3). pii: 97732. doi: 10.1172/jci.insight.97732. [Epub ahead of print]

17.

Functional loss of p53 cooperates with the in vivo microenvironment to promote malignant progression of gastric cancers.

Ohtsuka J, Oshima H, Ezawa I, Abe R, Oshima M, Ohki R.

Sci Rep. 2018 Feb 2;8(1):2291. doi: 10.1038/s41598-018-20572-1.

18.

Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis.

Enjoji S, Yabe R, Tsuji S, Yoshimura K, Kawasaki H, Sakurai M, Sakai Y, Takenouchi H, Yoshino S, Hazama S, Nagano H, Oshima H, Oshima M, Vitek MP, Matsuura T, Hippo Y, Usui T, Ohama T, Sato K.

Mol Cancer Res. 2018 Mar;16(3):554-563. doi: 10.1158/1541-7786.MCR-17-0393. Epub 2018 Jan 12.

PMID:
29330298
19.

Clinical Utility of a STAT3-Regulated miRNA-200 Family Signature with Prognostic Potential in Early Gastric Cancer.

Yu L, Wu D, Gao H, Balic JJ, Tsykin A, Han TS, Liu YD, Kennedy CL, Li JK, Mao JQ, Tan P, Oshima M, Goodall GJ, Jenkins BJ.

Clin Cancer Res. 2018 Mar 15;24(6):1459-1472. doi: 10.1158/1078-0432.CCR-17-2485. Epub 2018 Jan 12.

PMID:
29330205
20.

Laser Microdissection of Cellular Compartments for Expression Analyses in Cancer Models.

Han TS, Oshima M.

Methods Mol Biol. 2018;1725:143-153. doi: 10.1007/978-1-4939-7568-6_12.

PMID:
29322415
21.

Magnetic resonance imaging findings in central nervous system cryptococcosis: comparison between immunocompetent and immunocompromised patients.

Duarte SBL, Oshima MM, Mesquita JVDA, do Nascimento FBP, de Azevedo PC, Reis F.

Radiol Bras. 2017 Nov-Dec;50(6):359-365. doi: 10.1590/0100-3984.2016.0017.

22.

Hmga2 collaborates with JAK2V617F in the development of myeloproliferative neoplasms.

Ueda K, Ikeda K, Ikezoe T, Harada-Shirado K, Ogawa K, Hashimoto Y, Sano T, Ohkawara H, Kimura S, Shichishima-Nakamura A, Nakamura Y, Shikama Y, Mori T, Mason PJ, Bessler M, Morishita S, Komatsu N, Shide K, Shimoda K, Koide S, Aoyama K, Oshima M, Iwama A, Takeishi Y.

Blood Adv. 2017 Jun 14;1(15):1001-1015. doi: 10.1182/bloodadvances.2017004457. eCollection 2017 Jun 27.

23.

Regeneration of complex oral organs using 3D cell organization technology.

Oshima M, Ogawa M, Tsuji T.

Curr Opin Cell Biol. 2017 Dec;49:84-90. doi: 10.1016/j.ceb.2017.12.011. Epub 2017 Dec 28. Review.

24.

Combined Mutation of Apc, Kras, and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer.

Sakai E, Nakayama M, Oshima H, Kouyama Y, Niida A, Fujii S, Ochiai A, Nakayama KI, Mimori K, Suzuki Y, Hong CP, Ock CY, Kim SJ, Oshima M.

Cancer Res. 2018 Mar 1;78(5):1334-1346. doi: 10.1158/0008-5472.CAN-17-3303. Epub 2017 Dec 27.

PMID:
29282223
25.

Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism.

Deswaerte V, Nguyen P, West A, Browning AF, Yu L, Ruwanpura SM, Balic J, Livis T, Girard C, Preaudet A, Oshima H, Fung KY, Tye H, Najdovska M, Ernst M, Oshima M, Gabay C, Putoczki T, Jenkins BJ.

Cancer Res. 2018 Mar 1;78(5):1293-1307. doi: 10.1158/0008-5472.CAN-17-1887. Epub 2017 Dec 27.

PMID:
29282220
26.

MondoA Is an Essential Glucose-Responsive Transcription Factor in Human Pancreatic β-Cells.

Richards P, Rachdi L, Oshima M, Marchetti P, Bugliani M, Armanet M, Postic C, Guilmeau S, Scharfmann R.

Diabetes. 2018 Mar;67(3):461-472. doi: 10.2337/db17-0595. Epub 2017 Dec 27.

PMID:
29282201
27.

A novel role for OATP2A1/SLCO2A1 in a murine model of colon cancer.

Nakanishi T, Ohno Y, Aotani R, Maruyama S, Shimada H, Kamo S, Oshima H, Oshima M, Schuetz JD, Tamai I.

Sci Rep. 2017 Nov 29;7(1):16567. doi: 10.1038/s41598-017-16738-y.

28.

A New Conditionally Immortalized Human Fetal Brain Pericyte Cell Line: Establishment and Functional Characterization as a Promising Tool for Human Brain Pericyte Studies.

Umehara K, Sun Y, Hiura S, Hamada K, Itoh M, Kitamura K, Oshima M, Iwama A, Saito K, Anzai N, Chiba K, Akita H, Furihata T.

Mol Neurobiol. 2018 Jul;55(7):5993-6006. doi: 10.1007/s12035-017-0815-9. Epub 2017 Nov 11.

PMID:
29128907
29.

Hybrid approach to laparoscopic decapsulation combined with splenic artery balloon occlusion in a patient with carbohydrate antigen 19-9 producing splenic cysts.

Maeda E, Okano K, Suto H, Asano E, Oshima M, Kishino T, Fujiwara M, Yamamoto N, Sanomura T, Suzuki Y.

Asian J Endosc Surg. 2017 Nov;10(4):459-462. doi: 10.1111/ases.12376.

PMID:
29076276
30.

Alteration of molecular assembly of peroxiredoxins from hyperthermophilic archaea.

Nakamura T, Oshima M, Yasuda M, Shimamura A, Morita J, Uegaki K.

J Biochem. 2017 Dec 1;162(6):415-422. doi: 10.1093/jb/mvx045.

PMID:
28992240
31.

Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes.

Rouxel O, Da Silva J, Beaudoin L, Nel I, Tard C, Cagninacci L, Kiaf B, Oshima M, Diedisheim M, Salou M, Corbett A, Rossjohn J, McCluskey J, Scharfmann R, Battaglia M, Polak M, Lantz O, Beltrand J, Lehuen A.

Nat Immunol. 2017 Dec;18(12):1321-1331. doi: 10.1038/ni.3854. Epub 2017 Oct 9. Erratum in: Nat Immunol. 2018 Jun 7;:.

32.

Requisite role of vasohibin-2 in spontaneous gastric cancer formation and accumulation of cancer-associated fibroblasts.

Suzuki Y, Kitahara S, Suematsu T, Oshima M, Sato Y.

Cancer Sci. 2017 Dec;108(12):2342-2351. doi: 10.1111/cas.13411. Epub 2017 Oct 21.

33.

The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule.

Oshima M, Deitiker P, Jankovic J, Atassi MZ.

Immunol Invest. 2018 Jan;47(1):18-39. doi: 10.1080/08820139.2017.1368544. Epub 2017 Sep 11.

PMID:
28891721
34.

Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.

Oshima M, Iida-Klein A, Maruta T, Deitiker PR, Atassi MZ.

Autoimmunity. 2017 Sep;50(6):346-353. doi: 10.1080/08916934.2017.1367772. Epub 2017 Aug 29.

PMID:
28850269
35.

Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC.

Satoh K, Yachida S, Sugimoto M, Oshima M, Nakagawa T, Akamoto S, Tabata S, Saitoh K, Kato K, Sato S, Igarashi K, Aizawa Y, Kajino-Sakamoto R, Kojima Y, Fujishita T, Enomoto A, Hirayama A, Ishikawa T, Taketo MM, Kushida Y, Haba R, Okano K, Tomita M, Suzuki Y, Fukuda S, Aoki M, Soga T.

Proc Natl Acad Sci U S A. 2017 Sep 12;114(37):E7697-E7706. doi: 10.1073/pnas.1710366114. Epub 2017 Aug 28.

36.

Dielectric collapse at the LaAlO3/SrTiO3 (001) heterointerface under applied electric field.

Minohara M, Hikita Y, Bell C, Inoue H, Hosoda M, Sato HK, Kumigashira H, Oshima M, Ikenaga E, Hwang HY.

Sci Rep. 2017 Aug 25;7(1):9516. doi: 10.1038/s41598-017-09920-9.

37.

Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies.

Tanaka T, Nakajima-Takagi Y, Aoyama K, Tara S, Oshima M, Saraya A, Koide S, Si S, Manabe I, Sanada M, Nakayama M, Masuko M, Sone H, Koseki H, Iwama A.

J Exp Med. 2017 Oct 2;214(10):2901-2913. doi: 10.1084/jem.20170167. Epub 2017 Aug 21.

38.

Influences of HLA DRB1, DQA1 and DQB1 on T-cell recognition of epitopes and of larger regions of the botulinum neurotoxin molecule.

Deitiker P, Oshima M, Jankovic J, Atassi MZ.

Immunol Lett. 2017 Oct;190:257-264. doi: 10.1016/j.imlet.2017.07.016. Epub 2017 Aug 16.

PMID:
28823519
39.

Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus.

Okabe A, Funata S, Matsusaka K, Namba H, Fukuyo M, Rahmutulla B, Oshima M, Iwama A, Fukayama M, Kaneda A.

Sci Rep. 2017 Aug 11;7(1):7924. doi: 10.1038/s41598-017-08370-7.

40.

Bmal1 regulates inflammatory responses in macrophages by modulating enhancer RNA transcription.

Oishi Y, Hayashi S, Isagawa T, Oshima M, Iwama A, Shimba S, Okamura H, Manabe I.

Sci Rep. 2017 Aug 1;7(1):7086. doi: 10.1038/s41598-017-07100-3.

41.

Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.

Nakayama M, Sakai E, Echizen K, Yamada Y, Oshima H, Han TS, Ohki R, Fujii S, Ochiai A, Robine S, Voon DC, Tanaka T, Taketo MM, Oshima M.

Oncogene. 2017 Oct 19;36(42):5885-5896. doi: 10.1038/onc.2017.194. Epub 2017 Jun 19.

42.

A Prospective Phase II Trial of Neoadjuvant S-1 with Concurrent Hypofractionated Radiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.

Okano K, Suto H, Oshima M, Maeda E, Yamamoto N, Kakinoki K, Kamada H, Masaki T, Takahashi S, Shibata T, Suzuki Y.

Ann Surg Oncol. 2017 Sep;24(9):2777-2784. doi: 10.1245/s10434-017-5921-4. Epub 2017 Jun 12.

PMID:
28608121
43.

Clinical Results of Minimally Invasive Spine Stabilization for Spinal Metastases.

Uei H, Tokuhashi Y, Oshima M, Maseda M, Matsumoto K, Soma H, Nakayama E, Tachikawa Y.

Orthopedics. 2017 Jul 1;40(4):e693-e698. doi: 10.3928/01477447-20170522-02. Epub 2017 May 31.

PMID:
28558111
44.

Injection of inactive Bordetella pertussis and complete Freund's adjuvant with Torpedo californica AChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice.

Maruta T, Oshima M, Mosier DR, Atassi MZ.

Autoimmunity. 2017 Aug;50(5):293-305. doi: 10.1080/08916934.2017.1329831. Epub 2017 May 26.

PMID:
28548588
45.

Computational fluid dynamics study of intra-arterial chemotherapy for oral cancer.

Kitajima H, Oshima M, Iwai T, Ohhara Y, Yajima Y, Mitsudo K, Tohnai I.

Biomed Eng Online. 2017 May 15;16(1):57. doi: 10.1186/s12938-017-0348-5.

46.

Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition.

Rizq O, Mimura N, Oshima M, Saraya A, Koide S, Kato Y, Aoyama K, Nakajima-Takagi Y, Wang C, Chiba T, Ma A, Jin J, Iseki T, Nakaseko C, Iwama A.

Clin Cancer Res. 2017 Aug 15;23(16):4817-4830. doi: 10.1158/1078-0432.CCR-16-2735. Epub 2017 May 10.

PMID:
28490465
47.

Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer.

West AC, Tang K, Tye H, Yu L, Deng N, Najdovska M, Lin SJ, Balic JJ, Okochi-Takada E, McGuirk P, Keogh B, McCormack W, Bhathal PS, Reilly M, Oshima M, Ushijima T, Tan P, Jenkins BJ.

Oncogene. 2017 Sep 7;36(36):5134-5144. doi: 10.1038/onc.2017.121. Epub 2017 May 8.

PMID:
28481875
48.

Wetting Induced Oxidation of Pt-based Nano Catalysts Revealed by In Situ High Energy Resolution X-ray Absorption Spectroscopy.

Cui YT, Harada Y, Niwa H, Hatanaka T, Nakamura N, Ando M, Yoshida T, Ishii K, Matsumura D, Oji H, Ofuchi H, Oshima M.

Sci Rep. 2017 May 3;7(1):1482. doi: 10.1038/s41598-017-00639-1.

49.

Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia.

Togasaki E, Takeda J, Yoshida K, Shiozawa Y, Takeuchi M, Oshima M, Saraya A, Iwama A, Yokote K, Sakaida E, Hirase C, Takeshita A, Imai K, Okumura H, Morishita Y, Usui N, Takahashi N, Fujisawa S, Shiraishi Y, Chiba K, Tanaka H, Kiyoi H, Ohnishi K, Ohtake S, Asou N, Kobayashi Y, Miyazaki Y, Miyano S, Ogawa S, Matsumura I, Nakaseko C, Naoe T.

Blood Cancer J. 2017 Apr 28;7(4):e559. doi: 10.1038/bcj.2017.36.

50.

Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma.

Yokoyama M, Chiba T, Zen Y, Oshima M, Kusakabe Y, Noguchi Y, Yuki K, Koide S, Tara S, Saraya A, Aoyama K, Mimura N, Miyagi S, Inoue M, Wakamatsu T, Saito T, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Otsuka M, Miyazaki M, Yokosuka O, Iwama A.

Oncotarget. 2017 Mar 28;8(13):21315-21326. doi: 10.18632/oncotarget.15528.

Supplemental Content

Loading ...
Support Center